Skip to main content
. 2024 Nov 11;26(1):97–111. doi: 10.1007/s11154-024-09928-3

Table 2.

Baseline biochemical disease activity and glucose metabolism

Author and reference GH
(ng/mL)
IGF-1
(ULN)
Glucose (mg/dL) T2DM (%) A1c (%)
Corica G. et al. [21] 3.4 1.3 93.0 14.0 5.7
Urbani C. et al. [14] 4.3 1.9 104.0 38.0 5.8
Chiloiro S. et al. [24] 4.0 3.1 109.0 14.7 5.9
Araujo-Castro M. et al. [15] NA 3.3 110.5 29.2 6.4
Ruiz S. et al. [13] 19.0 1.8 NA 14.0 NA
Stelmachowska-Banaś M. et al. [33] 3.9 2.3 111.0 15.4 5.9
Witek P. et al. [34] 3.1 1.9 NA 10.3 5.6
Shimon I. et al. [37] 1.9 1.8 109.0 31.4 6.1
Gadelha M. et al. [12] 4.0 2.4 NA 22.0 5.9
Lasolle H. et al. [40] NA 1.7 101.0 NA 5.8
Wolf P. et al. [41] 7.8 1.6 NA 39.0 5.8

Abbreviatures: BMI: body mass index, GH: growth hormone, IGF-1: Insulin-like Growth Factor 1, ULN: upper limit of normal, T2DM, Type 2 diabetes mellitus